MolNFT v1 · #179317 · protein
Crystal structure of srtb-anchored collagen-binding adhesin fragment (residues 206-565) from clostridioides difficile strain 630
7K1U: “Crystal structure of srtb-anchored collagen-binding adhesin fragment (residues 206-565) from clostridioides…”. X-ray diffraction, 1 pocket (best druggability 0.28). MolNFT v1 #179317 on GenesisL1: 3D structure, binding sites and…
- PDB
- 7K1U
- Type
- protein
- Length
- 253 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Collagen-binding adhesin
- UniProt
- Q18DC3
- Pockets
- 1 · best druggability 0.28
Structure
x-ray diffraction · 1 distinct chain · 2% helix, 50% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Collagen-binding adhesin | protein | 253 | 2% helix, 50% strand | Q18DC3 |
Ligands and binding sites
- BTB · 2-[bis-(2-hydroxy-ethyl)-amino]-2-hydroxymethyl-propane-1,3-diol · additive · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 50 | 0.28 | 0.75 | 15 | empty |
Modifications
Observed in the structure: 3 modified, 1 isopeptide (engineered, isopeptide).
Compared structures
- 7K1U · Crystal Structure of SrtB-anchored Collagen-binding Adhesin Fragment (residues 206-565)… · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q18DC3
- Elsewhere: RCSB PDB 7K1U · PDBe 7K1U · UniProt Q18DC3
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.